Fluent Elara THC-CBD Blend Suppositories

$50.00

Balanced THC+CBD BlendElara is a blend of Cannabis sativa and Cannabis indica hybrid strains with an approximate 1:1 ratio of THC:CBD with only mild euphoria. Elara harmoniously blends the top characteristics of each strain into one product. Patients can benefit tremendously from the synergistic effects of THC + CBD in treating various types of medical conditions. Elara also contains a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of CBD+THC rich products for the treatment of all conditions approved for medical cannabis.

CBD Content: Approximately 50%

THC Content: Approximately 50%

THC to CBD Ratio: 1:1

Dosing Units: 30 mg / suppository (~15 mg CBD/suppository; ~15 mg THC/suppository)

Total Doses: 10 suppositories per package

Sold By: Fluent

Categories: Suppositories, CBD THC Balanced 1:1

Leave Your Review: Write A Review

Out of stock

Reviews

There are no reviews yet.

Be the first to review “Fluent Elara THC-CBD Blend Suppositories”

Your email address will not be published.

Product Description

Ideal for localized pain, cramps and inflammation with prolonged effects. The absorption rate is very high and like other suppositories, the application puts the medication closer to internal cellular walls so essential cannabinoids enter the bloodstream much more quickly.

Patients are recommended to initiate treatment on the evening of Day 1 with 1 application. Remove suppository from packaging and insert rectally or vaginally. After 1 – 2 hours, patients reassess symptoms.

If symptoms have improved or subsided, no additional applications are needed and patients can apply as needed.

Cash & CanPay Accepted

Elara® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.